A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort-authors' reply

dc.authorid	0000-0002-9983-0308
dc.authorid	0000-0001-8217-1767
dc.contributor.author	Cağ, Yasemin
dc.contributor.author	Vahaboğlu, Haluk
dc.date.accessioned	2025-05-10T19:54:58Z
dc.date.issued	2021
dc.department	İstanbul Medeniyet Üniversitesi
dc.description.abstract	[No abstract available]
dc.identifier.doi	10.1007/s10096-020-04099-w
dc.identifier.endpage	1352
dc.identifier.issn	0934-9723
dc.identifier.issn	1435-4373
dc.identifier.issue	6
dc.identifier.pmid	33439342
dc.identifier.scopus	2-s2.0-85099413562
dc.identifier.scopusquality	Q1
dc.identifier.startpage	1351
dc.identifier.uri	https://doi.org/10.1007/s10096-020-04099-w
dc.identifier.uri	https://hdl.handle.net/20.500.14730/13188
dc.identifier.volume	40
dc.identifier.wos	WOS:000607523700001
dc.identifier.wosquality	Q2
dc.indekslendigikaynak	Web of Science
dc.indekslendigikaynak	Scopus
dc.indekslendigikaynak	PubMed
dc.language.iso	en
dc.publisher	Springer
dc.relation.ispartof	European Journal of Clinical Microbiology & Infectious Diseases
dc.relation.publicationcategory	Diğer
dc.rights	info:eu-repo/semantics/openAccess
dc.snmz	KA_WOS_20250302
dc.title	A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort-authors' reply
dc.type	Letter

Dosyalar

Listeleniyor 1 - 1 / 1